Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | TACR1 | P25103 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL809052 | 0.98 | SLC1A1 (0.55) | SLC1A1CA1CA2CA7CA9 | |
| SCHEMBL809237 | 0.96 | SLC1A1 (0.54) | SLC1A1CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL5551687 | 0.96 | SLC1A1 (0.54) | SLC1A1CA1CA2CA7CA9 | |
| SCHEMBL5551683 | 0.86 | ALDH1A1 (0.52) | SLC1A1CA1CA2CA7CA9 | |
| SCHEMBL27740201 | 0.85 | SLC1A1 (0.48) | SLC1A1CA1CA2CA7CA9 | |
| SCHEMBL11025934 | 0.84 | ALDH1A1 (0.55) | SLC1A1CA1CA2CA7CA9 | |
| SCHEMBL6442451 | 0.83 | SMN1; SMN2 (0.47) | SLC1A1CA1CA2CA7CA9 | |
| SCHEMBL809238 | 0.83 | SLC1A1 (0.48) | SLC1A1CA1CA2CA7CA9 | |
| Potassium Ion SCHEMBL809092 | 0.83 | SLC1A1 (0.48) | SLC1A1CA1CA2CA7CA9 | |
| SCHEMBL31532269 | 0.81 | ALDH1A1 (0.47) | SLC1A1CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1588998-B1 | A process for the preparation of 2-chloro-3-(phenylmethoxy)propionic acid potassium salt | BRACCO IMAGING SPA (IT) | 2011-11-30 | — | — | EP | claimed |
| EP-1948590-B1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | BRACCO IMAGING SPA (IT) | 2010-08-18 | — | — | EP | claimed |
| JP-4476486-B2 | — | — | 2010-06-09 | — | — | JP | claimed |
| US-20090306424-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | BRACCO IMAGING S.P.A. (IT) | 2009-12-10 | — | — | US | claimed |
| US-7592482-B2 | Process for the preparation of contrast agents | BRACCO IMAGING S.P.A. (IT) | 2009-09-22 | — | — | US | claimed |
| US-20090118537-A1 | Process for the Preparation of Contrast Agents | BRACCO IMAGING S.P.A. (IT) | 2009-05-07 | — | — | US | claimed |
| EP-1948590-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | Bracco Imaging S.p.A. (IT) | 2008-07-30 | — | — | EP | claimed |
| WO-2007031390-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | BRACCO IMAGING S.P.A. (IT) | 2007-03-22 | — | — | WO | claimed |
| EP-1762563-A1 | Process for the preparation of contrast agents | BRACCO IMAGING S.p.A. (IT) | 2007-03-14 | — | — | EP | claimed |
| EP-1588998-A1 | A process for the preparation of 2-chloro-3-(phenylmethoxy)propionic acid potassium salt | Bracco Imaging S.p.A. (IT) | 2005-10-26 | — | — | EP | claimed |
| EP-1095009-B1 | A PROCESS FOR THE PREPARATION OF 4-CARBOXY- 5,8,11- TRIS(CARBOXYMETHYL)- 1-PHENYL- 2-OXA- 5,8,11- TRIAZATRIDECAN- 13-OIC ACID | BRACCO IMAGING SPA (IT) | 2005-06-15 | — | — | EP | claimed |
| JP-2002520305-A | — | — | 2002-07-09 | — | — | JP | claimed |
| EP-1095009-A2 | A PROCESS FOR THE PREPARATION OF 4-CARBOXY- 5,8,11- TRIS(CARBOXYMETHYL)- 1-PHENYL- 2-OXA- 5,8,11- TRIAZATRIDECAN- 13-OIC ACID | Bracco Imaging S.p.A. (IT) | 2001-05-02 | — | — | EP | claimed |
| US-6162947-A | Process for the preparation of 4-carboxy-5, 8,11-tris (carboxymethyl)-phenyl-2-oxa-5, 8 11-triazatridecan | DIBRA S.P.A. (IT) | 2000-12-19 | — | — | US | claimed |
| WO-2000002847-A2 | A PROCESS FOR THE PREPARATION OF 4-CARBOXY- 5,8,11- TRIS(CARBOXYMETHYL)- 1-PHENYL- 2-OXA- 5,8,11- TRIAZATRIDECAN- 13-OIC ACID | BRACCO S.P.A. (IT) | 2000-01-20 | — | — | WO | claimed |
| EP-1588998-B1 | A process for the preparation of 2-chloro-3-(phenylmethoxy)propionic acid potassium salt | BRACCO IMAGING SPA (IT) | 2011-11-30 | — | — | EP | disclosed |
| EP-1588998-B1 | A process for the preparation of 2-chloro-3-(phenylmethoxy)propionic acid potassium salt | BRACCO IMAGING SPA (IT) | 2011-11-30 | — | — | EP | disclosed |
| US-6162947-A | Process for the preparation of 4-carboxy-5, 8,11-tris (carboxymethyl)-phenyl-2-oxa-5, 8 11-triazatridecan | DIBRA S.P.A. (IT) | 2000-12-19 | — | — | US | disclosed |
| WO-2000002847-A2 | A PROCESS FOR THE PREPARATION OF 4-CARBOXY- 5,8,11- TRIS(CARBOXYMETHYL)- 1-PHENYL- 2-OXA- 5,8,11- TRIAZATRIDECAN- 13-OIC ACID | BRACCO S.P.A. (IT) | 2000-01-20 | — | — | WO | disclosed |
| WO-1999045968-A1 | MANGANESE CHELATES WITH HIGH RELAXIVITY IN SERUM | BRACCO S.P.A. (IT) | 1999-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306424-A1 | PROCESS FOR THE PREPARATION OF CONTRAST AGENTS | MGMT, CA14, CA4 | SLC1A1 2414/4885CA1 23/4885CA2 123/4885 |
| US-20090118537-A1 | Process for the Preparation of Contrast Agents | MGMT, CA14, CA4 | SLC1A1 2414/4885CA1 23/4885CA2 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.